PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers

Overview of attention for article published in Gynecologic Oncology, January 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 24 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,132 followers.

RT @SU2Cscience: Alessandro Santin, @SU2C Convergence Team Leader, published a paper in Gynelogic Oncology detailing how PI3K mutations med…

Alessandro Santin, @SU2C Convergence Team Leader, published a paper in Gynelogic Oncology detailing how PI3K mutations mediate resistance to afatinib in Her2/neu-overexpressing gynecological cancers. May be a biomarker for needed differential treatments…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.